Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons

Josef Pleticha, Christian Jeng-Singh, Rahaf Rezek, Manal Zaibak, Andreas S Beutler

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gene therapy using adeno-associated virus (AAV) is an attractive strategy to treat disorders of the peripheral nervous system (PNS), such as chronic pain or peripheral neuropathies. Although intrathecal (IT) administration of AAV has been the standard in the field for targeting the PNS, it lacks anatomical specificity and results in wide rostro-caudal distribution of the vector. An alternative approach is to deliver AAV directly to the peripheral nerve axon. The present study employed convection-enhanced delivery (CED) of a novel AAV serotype, AAVrh20, expressing enhanced green fluorescent protein (EGFP) into rat sciatic nerve investigating its efficacy, anatomical selectivity, and safety, compared to the IT route. Intraneural CED resulted in transduction confined to the ipsilateral L4 and L5 DRG while IT administration led to promiscuous DRG transduction encompassing the entire lumbar region bilaterally. The transduction rate for intraneural AAV administration was similar to IT delivery (24% for L4 and 31.5% for L5 DRG versus 50% for L4 and 19.5% for L5 DRG). The use of hyperosmotic diluent did not further improve the transduction efficiency. AAVrh20 was superior to reference serotypes previously described to be most active for each route. Intraneural CED of AAV was associated with transient allodynia that resolved spontaneously. These findings establish intraneural CED as an alternative to IT administration for AAV mediated gene transfer to the PNS and, based on a reference rodent model, suggest AAVrh20 as a superior serotype for targeting the PNS.

Original languageEnglish (US)
Pages (from-to)72-80
Number of pages9
JournalMolecular and Cellular Neuroscience
Volume60
DOIs
StatePublished - 2014

Fingerprint

Convection
Dependovirus
Sensory Receptor Cells
Diagnosis-Related Groups
Peripheral Nervous System
Peripheral Nervous System Diseases
Lumbosacral Region
Hyperalgesia
Sciatic Nerve
Peripheral Nerves
Chronic Pain
Genetic Therapy
Axons
Rodentia
Safety
Genes

Keywords

  • Adeno-associated virus rh20
  • Convection-enhanced delivery
  • Dorsal root ganglion
  • Intraneural
  • Intrathecal
  • Peripheral nervous system

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Medicine(all)

Cite this

Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons. / Pleticha, Josef; Jeng-Singh, Christian; Rezek, Rahaf; Zaibak, Manal; Beutler, Andreas S.

In: Molecular and Cellular Neuroscience, Vol. 60, 2014, p. 72-80.

Research output: Contribution to journalArticle

Pleticha, Josef ; Jeng-Singh, Christian ; Rezek, Rahaf ; Zaibak, Manal ; Beutler, Andreas S. / Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons. In: Molecular and Cellular Neuroscience. 2014 ; Vol. 60. pp. 72-80.
@article{6d522ed34cdb47b687f199c23f8aa57f,
title = "Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons",
abstract = "Gene therapy using adeno-associated virus (AAV) is an attractive strategy to treat disorders of the peripheral nervous system (PNS), such as chronic pain or peripheral neuropathies. Although intrathecal (IT) administration of AAV has been the standard in the field for targeting the PNS, it lacks anatomical specificity and results in wide rostro-caudal distribution of the vector. An alternative approach is to deliver AAV directly to the peripheral nerve axon. The present study employed convection-enhanced delivery (CED) of a novel AAV serotype, AAVrh20, expressing enhanced green fluorescent protein (EGFP) into rat sciatic nerve investigating its efficacy, anatomical selectivity, and safety, compared to the IT route. Intraneural CED resulted in transduction confined to the ipsilateral L4 and L5 DRG while IT administration led to promiscuous DRG transduction encompassing the entire lumbar region bilaterally. The transduction rate for intraneural AAV administration was similar to IT delivery (24{\%} for L4 and 31.5{\%} for L5 DRG versus 50{\%} for L4 and 19.5{\%} for L5 DRG). The use of hyperosmotic diluent did not further improve the transduction efficiency. AAVrh20 was superior to reference serotypes previously described to be most active for each route. Intraneural CED of AAV was associated with transient allodynia that resolved spontaneously. These findings establish intraneural CED as an alternative to IT administration for AAV mediated gene transfer to the PNS and, based on a reference rodent model, suggest AAVrh20 as a superior serotype for targeting the PNS.",
keywords = "Adeno-associated virus rh20, Convection-enhanced delivery, Dorsal root ganglion, Intraneural, Intrathecal, Peripheral nervous system",
author = "Josef Pleticha and Christian Jeng-Singh and Rahaf Rezek and Manal Zaibak and Beutler, {Andreas S}",
year = "2014",
doi = "10.1016/j.mcn.2014.04.004",
language = "English (US)",
volume = "60",
pages = "72--80",
journal = "Molecular and Cellular Neuroscience",
issn = "1044-7431",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons

AU - Pleticha, Josef

AU - Jeng-Singh, Christian

AU - Rezek, Rahaf

AU - Zaibak, Manal

AU - Beutler, Andreas S

PY - 2014

Y1 - 2014

N2 - Gene therapy using adeno-associated virus (AAV) is an attractive strategy to treat disorders of the peripheral nervous system (PNS), such as chronic pain or peripheral neuropathies. Although intrathecal (IT) administration of AAV has been the standard in the field for targeting the PNS, it lacks anatomical specificity and results in wide rostro-caudal distribution of the vector. An alternative approach is to deliver AAV directly to the peripheral nerve axon. The present study employed convection-enhanced delivery (CED) of a novel AAV serotype, AAVrh20, expressing enhanced green fluorescent protein (EGFP) into rat sciatic nerve investigating its efficacy, anatomical selectivity, and safety, compared to the IT route. Intraneural CED resulted in transduction confined to the ipsilateral L4 and L5 DRG while IT administration led to promiscuous DRG transduction encompassing the entire lumbar region bilaterally. The transduction rate for intraneural AAV administration was similar to IT delivery (24% for L4 and 31.5% for L5 DRG versus 50% for L4 and 19.5% for L5 DRG). The use of hyperosmotic diluent did not further improve the transduction efficiency. AAVrh20 was superior to reference serotypes previously described to be most active for each route. Intraneural CED of AAV was associated with transient allodynia that resolved spontaneously. These findings establish intraneural CED as an alternative to IT administration for AAV mediated gene transfer to the PNS and, based on a reference rodent model, suggest AAVrh20 as a superior serotype for targeting the PNS.

AB - Gene therapy using adeno-associated virus (AAV) is an attractive strategy to treat disorders of the peripheral nervous system (PNS), such as chronic pain or peripheral neuropathies. Although intrathecal (IT) administration of AAV has been the standard in the field for targeting the PNS, it lacks anatomical specificity and results in wide rostro-caudal distribution of the vector. An alternative approach is to deliver AAV directly to the peripheral nerve axon. The present study employed convection-enhanced delivery (CED) of a novel AAV serotype, AAVrh20, expressing enhanced green fluorescent protein (EGFP) into rat sciatic nerve investigating its efficacy, anatomical selectivity, and safety, compared to the IT route. Intraneural CED resulted in transduction confined to the ipsilateral L4 and L5 DRG while IT administration led to promiscuous DRG transduction encompassing the entire lumbar region bilaterally. The transduction rate for intraneural AAV administration was similar to IT delivery (24% for L4 and 31.5% for L5 DRG versus 50% for L4 and 19.5% for L5 DRG). The use of hyperosmotic diluent did not further improve the transduction efficiency. AAVrh20 was superior to reference serotypes previously described to be most active for each route. Intraneural CED of AAV was associated with transient allodynia that resolved spontaneously. These findings establish intraneural CED as an alternative to IT administration for AAV mediated gene transfer to the PNS and, based on a reference rodent model, suggest AAVrh20 as a superior serotype for targeting the PNS.

KW - Adeno-associated virus rh20

KW - Convection-enhanced delivery

KW - Dorsal root ganglion

KW - Intraneural

KW - Intrathecal

KW - Peripheral nervous system

UR - http://www.scopus.com/inward/record.url?scp=84900036393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900036393&partnerID=8YFLogxK

U2 - 10.1016/j.mcn.2014.04.004

DO - 10.1016/j.mcn.2014.04.004

M3 - Article

C2 - 24769104

AN - SCOPUS:84900036393

VL - 60

SP - 72

EP - 80

JO - Molecular and Cellular Neuroscience

JF - Molecular and Cellular Neuroscience

SN - 1044-7431

ER -